Image 1
Doxazosin Tablet
Product Images NDC 50090-3143
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 50090-3143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 2
This appears to be a chart or table indicating results from three different studies involving a drug called doxazosin mesylate in relation to the treatment of benign prostatic hypertrophy (BPH). The studies involved measuring maximum flow rate and symptom scores before and after treatment with either doxazosin mesylate or a placebo. The chart provides baseline measurements, mean measurements, and mean changes. There are notes regarding the duration of treatment and dosages given in each study, as well as the scores obtained using different questionnaires. The text also includes asterisks indicating statistically significant differences in results between the doxazosin mesylate group and the placebo group.*
Image 3
This document presents graphs showing the mean change in total symptom score and mean increase in maximum urinary flow rate (in mL/sec) from baseline after 14 weeks of treatment. There were 47 participants who received the drug mesylate and a placebo group. The doxazosin titration was up to a maximum of 8 mg. Statistical significance is denoted by asterisks in the graphs.*
Label Image (Lbl500903143)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
